The primary objective of the Scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies.
Benchmark:
BSE HEALTHCARE
Fund Manager:
Ramesh Mantri, . Dheeresh Pathak, Piyush Baranwal, Shariq Merchant
Tata India Pharma & Healthcare Fund | 20.97(6M) | 47.29(1Y) |
ITI Pharma & Healthcare Fund | 19.53(6M) | 41.08(1Y) |
This is a sector that is looking at renewed investor interest. And the fund could gain because of a fresh start.
Fund House AAUM:
Rs 631079.04 Lakhs(as on 31st December 2023)
Fund Manager:
Combined experience of above 20 years
If you are a risk taker then sure. This sector, although the index remains flattish, could provide decent management alpha.